Official UK procurement notice
ADHD prescribing and monitoring - CYP
Authority: NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD (NHS & healthcare)
What is being bought
Published requirement descriptionProvision of the primary care element of ADHD patient shared Care Arrangements for Children and Young People, which includes delivery of prescribing as required after positive diagnosis and stabilisation of medication by Specialist Provider.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1Suffolk and North East Essex (SNEE) ICB is establishing a prescribing and monitoring…Awarded
Suffolk and North East Essex (SNEE) ICB is establishing a prescribing and monitoring service for ADHD medications for CYP patients in NEE. This service will take on the primary care responsibilities as defined by the shared care agreements for these medications. This service is being set up in response to receiving formal notice from the North & South Essex LMC that they have advised GP practices in NEE to decline from participating in shared care agreements for ADHD medications for this cohorts of patients. This includes withdrawing from existing shared care agreements.
This service will share care for patients who are under the care of East Suffolk and North Essex NHS Foundation Trust who deliver commissioned pathways by SNEE ICB.
The objectives of the service are to:
- Provide patients with appropriate and safe care outside of the secondary care setting.
- Improve patient access to services.
- Deliver an innovative approach to service provision.
- Demonstrate improved quality and effectiveness of services for patients.
The service shall be available to all patients within NEE who are registered with a GP practice within North East Essex and under the care of ESNEFT (SNEE ICB commissioned Children's ADHD pathway) who have been diagnosed with ADHD and are being prescribed one or more of the medications. Access to the service is by referral from ESNEFT.
The provider will accept new patients who have been diagnosed with ADHD, have completed a minimum of 12 weeks of titration and has been stabilised on treatment by ESNEFT and patients referred into the service by ESNEFT who were previously prescribed and monitored by their NEE GP practice. The Provider will also be working with GP Practices who choose to continue with the monitoring or prescribing.
This contract will start on the 1st April 2025 for 12 months (1 year).
There will be an option to extend by a further 12 months (1 year) from 1st April 2026 - 31st March 2027
The value of this contract is an estimation based upon all patient data available at the time, therefore there is the potential for variation once the entirety of the circumstances and the number of shared care arrangements are understood with greater detail.
The ICB may wish to introduce additional services during the lifetime of the contract ("Contract modifications"). Such contract modifications will be contemplated where additional requirements are similar and or complementary to the services already included in the Specification, at any given time. Such expansion would be by the addition of services commissioned by the Authority as named in the Contract Notice. To this end, after the award of contract, there is a possibility that the contract may be varied as allowable in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 27 Feb 2025, 17:07 GMT
- Last source update
- 27 Feb 2025, 17:07 GMT
- FTS notice number
2025/S 000-007452- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04e876Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This award is being made urgently and the reason for the urgency was not foreseen by the ICB for the reasons outlined within this notice. This award is being made in order to prevent risk to patient and public safety, and the ICB is not able to satisfy the requirements of regulations 6 - 13 for the reasons outlined below.
In order to mobilise this interim new service within the timeframe given by the notice of GP practices in North East Essex, it is imperative that the provider has the relationships, digital and clinical processes required with the GP practices and with East Suffolk and North Essex NHS Foundation Trust (ESNEFT).
The following elements indicate the reasons for the direct award to the named provider:
•The critical timeline for implementation of this significant change
•The direct partnership - working arrangements between the practices of NE Essex and GP Primary Choice Ltd; this includes management of a collective LES, commissioned by the ICB with a range of implementation arrangements with practices
•The track record of delivery of high-quality services working with practices and system partners
•The working relationship between ESNEFT and GP Primary Choice Ltd
GP Primary Choice Ltd is a trusted system partner of ESNEFT as well as the practices. The pace required to deliver these new arrangements safely for this interim period demands these practical working relationships.
Insert Award decision-makers: Executive Committee 6th January 2025.
No conflicts of interest, or potential conflicts of interest, were declared by any decision makes.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| GP PRIMARY CHOICE LIMITEDSME | £587,120 † | — | Awarded |
Contracts
ADHD prescribing and monitoring - CYP · GP PRIMARY CHOICE LIMITEDSME
- Signed
- 19 Feb 2025
- Value
- £587,120
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- GP Primary Choice LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.